RPG Life Sciences Ltd - RPG LIFESCIENCE. Share Price

Sector: Pharmaceuticals | ISIN: INE105J01010
₹ 1,463.05 (-1.21%) icon27 May, 2024, 12:00:00 AM
Open
₹ 1,481.00
Prev. Close
₹ 1,481.00
Turnover(lac)
₹ 0.00
Day's High
₹ 1,482.20
Day's Low
₹ 1,434.70
52 Wk High
₹ 1,740.00
52 Wk Low
₹ 748.60
Book Value
₹ 238.99
Face Value
₹ 8.00
Mkt. Cap (Cr.)
₹ 2,419.74
P/E
27.98
EPS
53.00
Div. Yield
1.08

RPG Life Sciences Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 5/27/2024 12:00:00 AM

    ₹ 1463.05 -17.95 -1.21
  • Open
  • ₹ 1,481
  • Prev. Close
  • ₹ 1,481
  • Turnover(Lac.)
  • ₹ 206
  • Day's High
  • ₹ 1,482.2
  • Day's Low
  • ₹ 1,434.7
  • 52 Week's High
  • ₹ 1,740
  • 52 Week's Low
  • ₹ 748.6
  • Book Value
  • ₹ 238.99
  • Face Value
  • ₹ 8
  • Mkt Cap (₹ Cr.)
  • 2,419.74
  • P/E
  • 27.98
  • EPS
  • 53
  • Divi. Yield
  • 1.08

RPG Life Sciences Ltd Corporate Actions

23 Apr , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

25 Jan , 2024

12:00 AM

25 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

11 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

11 Oct , 2023

12:00 AM

07 Jul , 2023

12:00 AM

AGM

Announcement date: 07 Jul , 2023

View Details

21 Jul , 2023

12:00 AM

21 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

28 Apr , 2023

12:00 AM

Dividend

Dividend amount: 12
Announcement date: 28 Apr , 2023

View Details

No Record Found


RPG Life Sciences Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

RPG Life Sciences Ltd SHAREHOLDING SNAPSHOT
27 May , 2024 | 06:30 PM

PROMOTER - TOTAL72.81%

Indian: 72.81%

Foreign: 0%

NON-PROMOTER - TOTAL 27.19%

Institutions: 5.08%

Non-Institutions: 22.11%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

RPG Life Sciences Ltd FINANCIALS

View Profit & Loss Graph

RPG Life Sciences Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT RPG Life Sciences Ltd

  • H V Goenka
  • Chairman
  • Lalit S Kanodia
  • Independent Director
  • Mahesh S Gupta
  • Independent Director
  • Manoj K Maheshwari
  • Independent Director
  • Rajesh Shirambekar
  • Company Secretary
  • Narendra Ambwani
  • Independent Director
  • Sachin Nandgaonkar
  • Director
  • Zahabiya Khorakiwala
  • Independent Director
  • Yugal Sikri
  • Managing Director
  • Bhaskar Vemban Iyer
  • Addtnl Independent Director
  • Rajat Bhargava
  • Additional Director

Summary

RPG Life Sciences, formerly Searle India Ltd, started in 1968 as a joint venture with GD Searle, USA. In 1993, GD Searle withdrew from India and sold its holdings to RPG Group. The Company is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).The company is having research and development facilities that conform to international standards. It has Biotech R&D, API R&D and Formulations R&D. They are having TGA (Aus) and MHRA (UK) approved facilities at Thane in Maharashtra and Ankleshwar in Gujarat.RPG Life Sciences Ltd was incorporated on March 29, 2007 with the name RPG Pharmaceuticals Ltd. During the year 2007-08, as per the scheme of arrangement, the company acquired the pharmaceuticals business of Brabourne Enterprises Ltd along with all assets and liabilities pertaining to that business with effect from April 2, 2007 (the appointed date). In February 13, 2008, the name of the company was subsequently changed to RPG Life Sciences Ltd.During the year 2008-09, the company increased the production capacity of Bulk Drugs and Chemicals from 62 tonnes to 71 tonnes. They launched an oncology drug namely Exemestane. Also, they launched new products, namely Nufex Beta, Qugyl-O & Immunotec. In June 10, 2008, the equity shares of the company were listed on BSE and NSE with effect from June 10, 2008. In July 2008, the company commenced production in the new high capacity fermenters. During the year 2009-10,... Read More


Reports by RPG Life Sciences Ltd


Reports by RPG Life Sciences Ltd

Company FAQ

No Record Found